Roche reports positive data from SMA treatment trial
Roche has reported positive data from the dose finding Part I FIREFISH study of Evrysdi (risdiplam) in infants with symptomatic…
Roche has reported positive data from the dose finding Part I FIREFISH study of Evrysdi (risdiplam) in infants with symptomatic…
Israel’s Rambam Medical Health Care Campus and Ziv Medical Center researchers have begun a Phase II clinical trial of Constant Therapeutics’ lead drug candidate, TXA27, for Covid-19. A pharmaceutical formulation…
Takeda Pharmaceutical has dosed the first subject in its Phase I/II study of Novavax’s Covid-19 vaccine candidate, TAK-019, in Japan. The placebo-controlled study will assess the safety and immunogenicity of…
Irish company ICON has agreed to acquire contract research company PRA Health Sciences in a cash and stock deal valued at about $12bn. The acquisition brings two organisations together with…
Stealth BioTherapeutics has completed enrolment in the Phase II ReCLAIM-2 study (SPIAM-202) of its lead product candidate, elamipretide, in patients with dry age-related macular degeneration (AMD) with geographic atrophy (GA).…
NeuroRx has reported that the Phase IIb/III trial of Zyesami (aviptadil, previously RLF-100) showed multidimensional benefit in treating respiratory failure in critically ill Covid-19 patients. It was initially approved as…
Yale School of Medicine has announced a randomised clinical trial led by the Yale Cardiovascular Research Group (YCRG) to study a therapy combination to reduce complications in Covid-19 patients. YCRG…